abagovomab 24
abciximab 27
abituzumab 22
abrilumab 19
actoxumab 16
adalimumab 18
aducanumab 10
afasevikumab 14
alacizumab_pegol 12
alemtuzumab 22
alirocumab 17
amatuximab 36
andecaliximab 18
anifrolumab 20
anrukinzumab 18
aprutumab 15
aprutumab_ixadotin 15
arcitumomab 23
ascrinvacumab 7
atezolizumab 16
atinumab 15
avelumab 14
basiliximab 25
bavituximab 36
begelomab 22
benralizumab 24
bevacizumab_beta 20
bezlotoxumab 16
bimagrumab 13
bleselumab 12
blinatumomab 30
blosozumab 28
bococizumab 15
brazikumab 15
brentuximab_vedotin 26
briakinumab 15
brodalumab 9
brolucizumab 25
brontictuzumab 24
burosumab 17
cabiralizumab 25
camrelizumab 11
canakinumab 20
cantuzumab_ravtansin 44
carlumab 12
carotuximab 29
cergutuzumab_amunaleukin2 23
cergutuzumab_amunaleukin 23
certolizumab_pegol 25
cetiximab 45
citatuzumab_bogatox 27
cixutumumab 24
clivatuzumab_tetraxetan 21
codrituzumab 29
conatumumab 9
concizumab 29
crenezumab 18
crizanlizumab 25
crotedumab 20
dacetuzumab 21
daclizumab 10
dalotuzumab 32
dapirolizumab_pegol 23
daratumumab 14
dectrekumab 8
demcizumab 20
denosumab 10
depatuxizumab 21
depatuxizumab_mafodotin 21
dezamizumab 18
dinutuximab 34
diridavumab 18
domagrozumab 13
drozitumab 14
duligotuzumab 20
durvalumab 7
dusigitumab 11
efalizumab 30
efungumab 29
eldelumab 13
elezanumab 18
elgemtumab 11
elotuzumab 16
emactuzumab 17
emapalumab 25
emibetuzumab 14
enavatuzumab 23
enfortumab_vedotin 12
enoblituzumab 17
enokizumab 22
enoticumab 17
ensituximab 29
eptinezumab 18
erenumab 18
etaracizumab 15
etrolizumab 22
evinacumab 21
evolocumab 12
farletuzumab 8
fasinumab 21
fezakinumab 15
fibatuzumab 9
ficlatuzumab 19
firivumab 33
flanvotumab 18
fletikumab 18
foralumab 10
foravirumab 13
fremanezumab 27
fresolimumab 17
fulranumab 19
futuximab 22
galcanezumab 18
ganitumab 26
gantenerumab 11
gemetuzumab 24
gemtuzumab2 25
gemtuzumab 19
gevokizumab 21
girentuximab 27
glembatumumab 16
glembatumumab_vedotin 16
guselkumab 22
ibalizumab 24
ibritumomab 28
icrucumab 9
idarucizumab 34
ifabotuzumab 9
imalumab 17
imgatuzumab 19
inclacumab 17
indatuximab_ravtansin 29
indusatumab 11
inebilizumab 22
intetumumab 10
iodine_girentuximab 28
ipilimumab 3
iratumumab 6
isatuximab 33
itolizumab 27
ixekizumab 30
labetuzumab_govitecan 18
lambrolizumab 23
lampalizumab 22
lanadelumab 18
landogrozumab 18
laprituximab 23
lebrikizumab 34
lendalizumab 22
lenzilumab 15
lifastuzumab_vedotin 25
ligelizumab 20
lilotomab 32
lirilumab 21
lodelcizumab 16
lokivetmab 23
lorvotuzumab_mertansin 25
lucatumumab 27
lumretuzumab 16
lupartumab 13
lutikizumab 20
margetuximab 29
milatuzumab 39
mirvetuximab 28
mirvetuximab_soravtansin 28
modotuximab 35
mogamulizumab 31
monalizumab 16
motavizumab 31
moxetumomab_pasudotox 31
namilumab 16
naratuximab 24
naratuximab_emtansin 24
narnatumab 14
navicixizumab2 26
navicixizumab 23
navivumab 32
necitumumab 10
nemolizumab 24
nesvacumab 14
nivolumab 12
obiltoxaximab 21
obinutuzumab 35
ocaratuzumab 26
ofatumumab 18
olaratumab 19
olokizumab 24
omalizumab 19
onartuzumab 21
ontuxizumab 22
opicinumab 14
orticumab 15
otelixizumab 36
oxelumab 12
ozanezumab 31
pamrevlumab 11
panobacumab 30
parsatuzumab 24
pasotuxizumab 23
pateclizumab 14
patritumab 17
pembrolizumab 23
perakizumab 21
pidilizumab 17
pinatuzumab_vedotin 19
plozalizumab 33
pogalizumab 22
polatuzumab_vedotin 22
ponezumab 37
prezalumab 14
pritoxaximab 28
quilizumab 19
racotumomab 26
radretumab 14
ralpancizumab 20
ramucirumab 14
ranevetmab 27
ranibizumab 23
refanezumab 22
remtolumab 18
rilotumumab 12
rinucumab 17
risankizumab 32
rituximab 17
rivabazumab 17
robatumumab 20
roledumab 28
romosozumab 18
rontalizumab 19
rosmantuzumab 21
rozanolixizumab 20
sacituzumab 27
sacituzumab_govitecan 27
samalizumab 22
sapelizumab 22
sarilumab 16
secukinumab 12
seribantumab 17
setoxaximab 39
sifalimumab 8
siltuximab 25
simtuzumab 24
sirukumab 12
solanezumab 26
solitomab 23
stamulumab 16
suptavumab 19
suvizumab 17
tabalumab 9
tadocizumab 14
tamtuvetmab 30
tanezumab 21
tarextumab 11
tavolixizumab 18
telisotuzumab 26
teplizumab 17
tesidolumab 20
tezepelumab 22
tigatuzumab 17
tildrakizumab 19
timolumab 13
tisotumab 12
tosatoxumab 37
tositumomab 28
tralokinumab 22
trastuzumab 22
tregalizumab 23
trevogrumab 12
ublituximab 28
urelumab 16
ustekinumab 27
utomilumab 26
vadastuximab 23
vadastuximab_talirin 23
vandortuzumab_vedotin 14
vantictumab 19
vanucizumab2 20
vanucizumab 26
varlilumab 13
vatelizumab 21
vedolizumab 22
veltuzumab 13
vesencumab 12
vorsetuzumab 19
vorsetuzumab_mafodotin 19
vunakizumab 28
xentuzumab 17
zatuximab 35
